• Home
  • Valpharma Group

Valpharma Group

About Valpharma Group

Since more than 40 years, VALPHARMA has been specialized in the development and contract manufacture of modified release products in capsules (hard-soft) and tablets, with own technology, supplying them to pharmaceutical companies worldwide. Its own R&D Department develops annually many new products in modified release form with own patents, changing posology from three or more daily dosings into once-twice daily dosing, optimizing pharmaceutical effects and reducing side-effects. Authorized by the Italian, Brazilian, Iranian, Ivory Coast, Japanese, Turkish, Taiwanese and United Arab Emira...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • IT
  • 2015
    On CPHI since
View company profile
Contact info
Show contact info Hide contact info
Meet us at

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024
View Exhibitor Profile

Products from Valpharma Group (5)

  • DILTIAZEM HCl S.R. CAPSULES 200 mg - 300 mg - (New Product)

    Product DILTIAZEM HCl S.R. CAPSULES 200 mg - 300 mg - (New Product)

    Valpharma provides a wide range of products which inlcudes DILTIAZEM HCl S.R. CAPSULES 200 mg - 300 mg for the treatment of hypertension, angina pectoris and some types of arrhythmia.Diltiazem is a nondihydropyridines (non-DHP) calcium channel blocker used in the therapy and prophylaxis of coronary ins...
  • GLICLAZIDE S.R. TABLETS 30 mg - (New Product)

    Product GLICLAZIDE S.R. TABLETS 30 mg - (New Product)

    Valpharma provides a wide range of products which includes GLICLAZIDE S.R. TABLETS 30 mg for the therapy of maturity onset Diabetes Mellitus (non-insulin-dependant or Type II), where dietary management alone has been  insufficient.Gliclazide is an oral hypoglycemic used for the control of blood glucos...
  • MELATONIN S.R. TABLETS 2 mg (New product)

    Product MELATONIN S.R. TABLETS 2 mg (New product)

    Valpharma provides a wide range of pharmaceutical products among which  MELATONIN S.R TABLETS 2 mg (a product under development).Melatonin S.R. tablets 2 mg is indicated as monotherapy for the short-term treatment of primary insomnia characterized by difficulty in getting to sleep and in keeping t...
  • E.C. ESOMEPRAZOLE 20 mg and 40 mg capsules (Product under development)

    Product E.C. ESOMEPRAZOLE 20 mg and 40 mg capsules (Product under development)

    Gastro-resistant capsules indicated for the treatment of acid-reflux disorders.
  • I.R. APIXABAN 2,5 mg and 5 mg tablets (Product under development)

    Product I.R. APIXABAN 2,5 mg and 5 mg tablets (Product under development)

    Anticoagulant (blood thinner) that reduces blood clotting and reduces the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.